BRPI0606520A2 - tripeptìdeo e tetrapeptìdeo tioéteres - Google Patents

tripeptìdeo e tetrapeptìdeo tioéteres

Info

Publication number
BRPI0606520A2
BRPI0606520A2 BRPI0606520-1A BRPI0606520A BRPI0606520A2 BR PI0606520 A2 BRPI0606520 A2 BR PI0606520A2 BR PI0606520 A BRPI0606520 A BR PI0606520A BR PI0606520 A2 BRPI0606520 A2 BR PI0606520A2
Authority
BR
Brazil
Prior art keywords
tripeptide
tetrapeptide
thioethers
chemotherapeutic agents
bone marrow
Prior art date
Application number
BRPI0606520-1A
Other languages
English (en)
Inventor
Natalia Aurrecoechea
Andrew B Kelson
Robert W Macsata
Louise Robinson
Anthony J Sanchez
Nicholas M Santiago
Steven R Schow
Reyna J Simon
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Publication of BRPI0606520A2 publication Critical patent/BRPI0606520A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

TRIPEPTìDEO E TETRAPEPTIDEO TIOéTERES. A presente invenção refere-se a um tripeptídeo e tetrapeptídeo tioéteres, composições farmacêuticas contendo os mesmos, seu uso farmacêutico, e sua preparação. Os compostos são úteis em potencialização de efeitos citotóxicos de agentes quimioterapêuticos em células de tumor, exercer seletivamente toxidez em células de tumor, elevação de produção de progenitores de GM em medula óssea, estimulação de diferenciação de medula óssea, mitigação de efeitos mielo-supressivos de agentes quimioterapêuticos, e modulação de hematopoiese em medula óssea.
BRPI0606520-1A 2005-01-06 2006-01-04 tripeptìdeo e tetrapeptìdeo tioéteres BRPI0606520A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64193205P 2005-01-06 2005-01-06
PCT/US2006/000219 WO2006074249A1 (en) 2005-01-06 2006-01-04 Tripeptide and tetrapeptide thioethers

Publications (1)

Publication Number Publication Date
BRPI0606520A2 true BRPI0606520A2 (pt) 2009-06-30

Family

ID=36123437

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0606520-1A BRPI0606520A2 (pt) 2005-01-06 2006-01-04 tripeptìdeo e tetrapeptìdeo tioéteres
BRPI0606396-9A BRPI0606396A2 (pt) 2005-01-06 2006-01-05 sulfonas tripeptìdicas e tetrapeptìdicas, composição farmacêutica contendo as mesmas, uso relacionado e método de preparação das referidas sulfonas

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0606396-9A BRPI0606396A2 (pt) 2005-01-06 2006-01-05 sulfonas tripeptìdicas e tetrapeptìdicas, composição farmacêutica contendo as mesmas, uso relacionado e método de preparação das referidas sulfonas

Country Status (24)

Country Link
US (2) US7129215B2 (pt)
EP (2) EP1833978B1 (pt)
JP (2) JP4903716B2 (pt)
KR (2) KR101244609B1 (pt)
CN (2) CN101090977B (pt)
AR (2) AR051889A1 (pt)
AT (2) ATE410520T1 (pt)
AU (2) AU2006204022B2 (pt)
BR (2) BRPI0606520A2 (pt)
CA (2) CA2587284C (pt)
DE (2) DE602006003064D1 (pt)
DK (2) DK1833978T3 (pt)
EA (2) EA200701398A1 (pt)
ES (2) ES2314890T3 (pt)
HR (2) HRP20090128T3 (pt)
IL (2) IL182836A (pt)
MX (2) MX2007008255A (pt)
NZ (2) NZ555362A (pt)
PL (2) PL1833978T3 (pt)
PT (2) PT1833978E (pt)
SI (2) SI1833978T1 (pt)
TW (2) TWI317738B (pt)
WO (2) WO2006074249A1 (pt)
ZA (2) ZA200704487B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198247B2 (en) * 2004-12-21 2012-06-12 Telik, Inc. Process for and intermediates in the preparation of canfosfamide and its salts
CN101090977B (zh) * 2005-01-06 2013-04-10 泰立克公司 三肽和四肽硫醚
US20070154963A1 (en) * 2005-12-30 2007-07-05 Danying Cai Method to determine whether a compound is a cellular GSTpi inhibitor
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
EP2091914A4 (en) * 2006-11-08 2010-12-29 Chongxi Yu TRANSDERMAL ADMINISTRATION SYSTEMS FOR PEPTIDES AND RELATED CONNECTIONS
AU2016213759B2 (en) * 2006-11-08 2018-03-29 Chongxi Yu Transdermal delivery systems of peptides and related compounds
JP2010529101A (ja) 2007-06-04 2010-08-26 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
CN108191846B (zh) 2008-12-04 2021-08-20 于崇曦 高穿透性组合物及其应用
DE102008060888A1 (de) 2008-12-09 2010-06-10 Evonik Stockhausen Gmbh Verfahren zur Herstellung von Acrolein umfassend die Aufarbeitung einer Rohglycerin-Phase
EP2660247A3 (en) 2009-05-08 2014-09-03 Chongxi Yu High penetration prodrug compositions of peptides and peptide-related compounds
CN102939300A (zh) 2010-06-07 2013-02-20 泰立克公司 无溶剂化晶体依泽替米贝盐酸盐d型的制备
WO2011156045A2 (en) * 2010-06-07 2011-12-15 Telik, Inc. Tablet formulation of ezatiostat
US20130035389A1 (en) * 2011-08-05 2013-02-07 Telik, Inc. Methods for treating myelodysplastic syndrome with ezatiostat
JP5970439B2 (ja) * 2013-09-20 2016-08-17 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
CN106146616A (zh) * 2015-04-03 2016-11-23 浙江海正药业股份有限公司 环肽类化合物及其制备和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599903A (en) 1992-04-03 1997-02-04 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
US5786336A (en) * 1991-04-29 1998-07-28 Terrapin Technologies, Inc. Target-selective protocols based on mimics
US5556942A (en) 1991-04-29 1996-09-17 Terrapin Technologies, Inc. Glutathione S-transferase-activated compounds
US5955432A (en) 1992-04-03 1999-09-21 Terrapin Technologies, Inc. Metabolic effects of certain glutathione analogs
US5767086A (en) 1992-04-03 1998-06-16 Terrapin Technologies, Inc. Bone marrow stimulation by certain glutathione analogs
CA2105492C (en) 1993-09-03 2000-02-01 Lawrence M. Kauvar Glutathione analogs and paralog panels comprising glutathione mimics
US5908919A (en) * 1993-10-01 1999-06-01 Terrapin Technologies Urethane mediated, GST specific molecular release systems
JPH11507056A (ja) * 1995-06-07 1999-06-22 テラピン テクノロジーズ、インク． グルタチオンアナログの代謝的効果
GB2332676B (en) * 1996-09-02 2001-01-24 Univ Manchester Metropolitan S-Blocked glutathiones
US6627732B1 (en) 1998-04-16 2003-09-30 Teijin Limited Glutathione derivatives and their dosage forms
PT1143992E (pt) 1999-01-27 2005-05-31 Telik Inc Composicoes farmaceuticas contendo analogos de glutationa
US7029695B2 (en) 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
TWI323662B (en) * 2002-11-15 2010-04-21 Telik Inc Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
CN101090977B (zh) 2005-01-06 2013-04-10 泰立克公司 三肽和四肽硫醚

Also Published As

Publication number Publication date
IL182836A0 (en) 2007-08-19
KR101244609B1 (ko) 2013-03-25
ZA200704487B (en) 2008-09-25
JP4903716B2 (ja) 2012-03-28
PL1833978T3 (pl) 2009-04-30
CA2587310A1 (en) 2006-07-13
SI1833842T1 (sl) 2009-04-30
PT1833842E (pt) 2008-12-11
DE602006003063D1 (de) 2008-11-20
JP2008526859A (ja) 2008-07-24
SI1833978T1 (sl) 2009-04-30
AU2006203901A1 (en) 2006-07-13
AR051889A1 (es) 2007-02-14
ZA200704488B (en) 2008-09-25
TW200635948A (en) 2006-10-16
ES2314891T3 (es) 2009-03-16
CA2587284A1 (en) 2006-07-13
NZ555361A (en) 2009-05-31
CA2587310C (en) 2013-11-12
MX2007008255A (es) 2007-09-11
NZ555362A (en) 2009-05-31
DK1833978T3 (da) 2009-02-09
IL183107A0 (en) 2007-09-20
HRP20090134T3 (hr) 2009-04-30
US20060148719A1 (en) 2006-07-06
JP2008526880A (ja) 2008-07-24
HRP20090128T3 (hr) 2009-04-30
DE602006003064D1 (en) 2008-11-20
EA200701399A1 (ru) 2008-02-28
KR20070091611A (ko) 2007-09-11
CA2587284C (en) 2014-03-25
WO2006074409A1 (en) 2006-07-13
WO2006074249A1 (en) 2006-07-13
EA200701398A1 (ru) 2007-12-28
KR20070104391A (ko) 2007-10-25
ES2314890T3 (es) 2009-03-16
MX2007008254A (es) 2007-09-11
HK1106796A1 (en) 2008-03-20
US20060160749A1 (en) 2006-07-20
TWI317739B (en) 2009-12-01
ATE410520T1 (de) 2008-10-15
ATE410440T1 (de) 2008-10-15
IL182836A (en) 2010-11-30
EP1833978B1 (en) 2008-10-08
EP1833842A1 (en) 2007-09-19
AU2006204022B2 (en) 2011-01-20
TWI317738B (en) 2009-12-01
CN101090977B (zh) 2013-04-10
HK1106778A1 (en) 2008-03-20
DK1833842T3 (da) 2009-02-09
AU2006204022A1 (en) 2006-07-13
CN101080418A (zh) 2007-11-28
PL1833842T3 (pl) 2009-04-30
CN101090977A (zh) 2007-12-19
AR051890A1 (es) 2007-02-14
AU2006203901B2 (en) 2011-06-02
TW200635949A (en) 2006-10-16
EP1833978A1 (en) 2007-09-19
JP4903717B2 (ja) 2012-03-28
EP1833842B1 (en) 2008-10-08
BRPI0606396A2 (pt) 2009-06-23
WO2006074409A9 (en) 2006-12-14
IL183107A (en) 2010-11-30
US7192918B2 (en) 2007-03-20
PT1833978E (pt) 2008-12-02
US7129215B2 (en) 2006-10-31

Similar Documents

Publication Publication Date Title
TW200505890A (en) Breast cancer-resistant protein inhibitor
BR0108678A (pt) Novos compostos
SE0301700D0 (sv) Novel compounds
WO2004013093A3 (en) Cytotoxic agents containing novel potent taxanes and their therapeutic use
CR9942A (es) Inhibidores de proteina activadora de la 5-lipoxigenasa (flap)
AR047928A1 (es) Derivados de tetrahidropiridoindol
BR0111667A (pt) Novos compostos
BRPI0606396A2 (pt) sulfonas tripeptìdicas e tetrapeptìdicas, composição farmacêutica contendo as mesmas, uso relacionado e método de preparação das referidas sulfonas
GEP20115231B (en) 2-amino-7,8-dihydro-6h-pyrido [4,3-d] pyrimidin-5-ones
BRPI0414948A (pt) derivados de pirazolo-e-imidazo pirimidina
BR0302496A (pt) Composições farmacêuticas com atividade antibiótica
EA200700976A1 (ru) Соединения в виде молекул-конъюгатов, обладающих повышенной активностью в отношении включения клеткой
BRPI0413428A (pt) xarope seco contendo laratadina
BRPI0412989A (pt) combinação farmacêutica útil para mobilização de célula-tronco
CY1109541T1 (el) Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
BRPI0416745A (pt) novos compostos
DK1142905T3 (da) Hidtil ukendt depsipeptidforbindelse
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"
WO2007077318A3 (fr) Utilisation d'un extrait peptidique de riz en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
AU6749401A (en) Use of aloe-emodin in the treatment of neuroectodermal tumors
MY143821A (en) Biologically active peptide comprising tyrosyl-seryl-valine (ysv)
SV2006002238A (es) Inhibidores de la adenilato ciclasa soluble ref. p-sv-78. 959/gh
BRPI0516569A (pt) derivados de 1,2,4-triazolilaminoaril(heteroaril)sulfonamida
AU2003229202A1 (en) Compositions comprising hepoxilin analogs and their use in the treatment of cancer

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: REF. A RPI NO 2154 DE 17/04/2012. ANULACAO DA EXIGENCIA 6.6 POR TER SIDO INDEVIDA. REQUERENTE NAO APRESENTOU RESPOSTA A EXIGENCIA CONFORME DISPOE A RESOLUCAO 207 DE 24/04/2009, ENTRETANTO, A RESPOSTA CONSTA NO FORMULARIO DE DEPOSITO.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2342 DE 24-11-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.